Back to Amipro Homepage
E-400 Selenium
Shopping cart is empty.
  • E-400 Selenium

    E-400 Selenium

    Antioxidant Protection Formula

    • R240,75
      1-11 R274,46
      12+ R253,34


    E-400 Selenium features selenium and natural-source vitamin E.
    Offers excellent antioxidant protection.
    Delivers an especially powerful combination of nutrients that help protect tissues against oxidative damage.
    Features selenium, a trace mineral that functions in the body as a component of the antioxidant enzyme glutathione peroxidase.

    Serving Size: 1 Tablet

    Ingredient Amount    Daily Value
    Vitamin E (as d-alpha tocopheryl succinate) 400 IU  1333% 
    Calcium 97 mg  10% 
    Phosphorus 74 mg  7% 
    Selenium (as selenium L-aspartate) 50 mcg  71% 

    Other Ingredients: Dicalcium phosphate, microcrystalline cellulose, silica, stearic acid (vegetable), magnesium stearate (vegetable), croscarmellose sodium, and coating (water, hypromellose, medium chain triglycerides , and hydroxypropylcellulose).

    Directions: Take one tablet up to twice daily with meals or as directed by your healthcare practitioner.

    Caution: Keep out of the reach of children.

    Storage: Keep tightly closed in a cool, dry place.

    This product is Gluten Free and Vegetarian.

    Formulated to Exclude: Wheat, gluten, soy, dairy products, egg, nuts, tree nuts, fish, crustacean shellfish, colors, artificial sweeteners, and preservatives.


     

    Disclaimer

    Certain persons, considered experts, may disagree with one or more of the foregoing statements, but the same are deemed, nevertheless, to be based on sound and reliable authority. No such statements shall be construed as a claim or representation as to Amipro products, that they are offered for the diagnosis, cure, mitigation, treatment or prevention of any disease.



    Practitioners Only Content

    Take one tablet up to twice daily with meals or as directed by your healthcare practitioner.

    711068-001

    No related resources.

Recent News

No news found.